193 related articles for article (PubMed ID: 20959990)
1. Long-term urinary adverse effects of pelvic radiotherapy.
Elliott SP; Malaeb BS
World J Urol; 2011 Feb; 29(1):35-41. PubMed ID: 20959990
[TBL] [Abstract][Full Text] [Related]
2. Urinary adverse effects of pelvic radiotherapy.
Liberman D; Mehus B; Elliott SP
Transl Androl Urol; 2014 Jun; 3(2):186-95. PubMed ID: 26813159
[TBL] [Abstract][Full Text] [Related]
3. Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy.
Sewell JM; Rao A; Elliott SP
Urology; 2013 Aug; 82(2):335-40. PubMed ID: 23746713
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers.
Krengli M; Pisani C; Deantonio L; Surico D; Volpe A; Surico N; Terrone C
Radiat Oncol; 2017 Jan; 12(1):18. PubMed ID: 28100242
[TBL] [Abstract][Full Text] [Related]
5. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
[TBL] [Abstract][Full Text] [Related]
6. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire.
Nguyen LN; Pollack A; Zagars GK
Urology; 1998 Jun; 51(6):991-7. PubMed ID: 9609638
[TBL] [Abstract][Full Text] [Related]
7. Pelvic radiotherapy in the setting of rheumatoid arthritis: Refining the paradigm.
Felefly T; Mazeron R; Huertas A; Canova CH; Maroun P; Kordahi M; Morice P; Deutsch É; Haie-Méder C; Chargari C
Cancer Radiother; 2017 Apr; 21(2):109-113. PubMed ID: 28363728
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
[TBL] [Abstract][Full Text] [Related]
9. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Matta R; Chapple CR; Fisch M; Heidenreich A; Herschorn S; Kodama RT; Koontz BF; Murphy DG; Nguyen PL; Nam RK
Eur Urol; 2019 Mar; 75(3):464-476. PubMed ID: 30573316
[TBL] [Abstract][Full Text] [Related]
10. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.
Crook J; Esche B; Futter N
Urology; 1996 Mar; 47(3):387-94. PubMed ID: 8633407
[TBL] [Abstract][Full Text] [Related]
11. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity.
Peterson JL; Buskirk SJ; Heckman MG; Diehl NN; Bernard JR; Tzou KS; Casale HE; Bellefontaine LP; Serago C; Kim S; Vallow LA; Daugherty LC; Ko SJ
Med Dosim; 2014; 39(1):12-7. PubMed ID: 24099966
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.
Katsanos KH; Briasoulis E; Tsekeris P; Batistatou A; Bai M; Tolis C; Capizzello A; Panelos I; Karavasilis V; Christodoulou D; Tsianos EV
J Exp Clin Cancer Res; 2010 Jun; 29(1):68. PubMed ID: 20537164
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.
Yalman D; Arican A; Ozsaran Z; Celik OK; Yürüt V; Esassolak M; Haydaroglu A
Eur J Gynaecol Oncol; 2002; 23(1):58-62. PubMed ID: 11876395
[TBL] [Abstract][Full Text] [Related]
14. [Normal tissue tolerance to external beam radiation therapy: bladder].
Pointreau Y; Atean I; Durdux C
Cancer Radiother; 2010 Jul; 14(4-5):363-8. PubMed ID: 20435498
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
16. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S; Tyldesley S; Morris WJ; Keyes M; Halperin R; Pai H; McKenzie M; Duncan G; Morton G; Hamm J; Murray N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):286-295. PubMed ID: 28433432
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
Chen RC; Zhang Y; Chen MH; McMahon E; Loffredo M; McPherson CP; Nguyen AU; Nguyen PL; D'Amico AV
BJU Int; 2012 Dec; 110(11):1690-5. PubMed ID: 22502770
[TBL] [Abstract][Full Text] [Related]
18. [Urine-flow disorders as complication following radiotherapy].
Breit A
Langenbecks Arch Chir; 1969; 325():644-53. PubMed ID: 5372379
[No Abstract] [Full Text] [Related]
19. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.
Klopp AH; Yeung AR; Deshmukh S; Gil KM; Wenzel L; Westin SN; Gifford K; Gaffney DK; Small W; Thompson S; Doncals DE; Cantuaria GHC; Yaremko BP; Chang A; Kundapur V; Mohan DS; Haas ML; Kim YB; Ferguson CL; Pugh SL; Kachnic LA; Bruner DW
J Clin Oncol; 2018 Aug; 36(24):2538-2544. PubMed ID: 29989857
[TBL] [Abstract][Full Text] [Related]
20. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
